Lysosomal storage disorders
Lysosomal Storage Disorders in the Newborn
19
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
6
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy
14
Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses
12
Reliability of enzyme assays in dried blood spots for diagnosis of 4 lysosomal storage disorders
7
Histopathologic Correlates of Radial Stripes on MR Images in Lysosomal Storage Disorders
5
Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug act
9
Lysosomal storage disorders: Molecular basis and laboratory testing
14
Recent advances in gene therapy for lysosomal storage disorders
13
Newborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier Strategy
10
2013/14 NHS STANDARD CONTRACT FOR LYSOSOMAL STORAGE DISORDERS SERVICE (CHILDREN)
39
Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders
16
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders.
8
Relative acidic compartment volume as a lysosomal storage disorder–associated biomarker
10
Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc
11
Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder
16
Diagnostic methods for Lysosomal Storage Disease
10
Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases
10
Differentiation of norm and pathology during selective biochemical skreening of lysosomal storage diseases with increased excretion of oligosaccharides
9
Parkinson's disease and metal storage disorders: a systematic review.
16